Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has received an average rating of “Hold” from the five research firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating on the […]
StockNews.com assumed coverage on shares of AMCON Distributing (NYSEAMERICAN:DIT – Free Report) in a research report sent to investors on Saturday. The brokerage issued a hold rating on the stock. Separately, TheStreet downgraded AMCON Distributing from a b- rating to a c rating in a research report on Thursday, January 18th. Get Our Latest Research […]
Pekin Hardy Strauss Inc. lessened its position in shares of Freeport-McMoRan Inc. (NYSE:FCX – Free Report) by 1.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 63,890 shares of the natural resource company’s stock after selling 750 shares during the quarter. Pekin Hardy […]
DURECT Co. (NASDAQ:DRRX – Get Free Report) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totalling 927,500 shares, a decline of 10.0% from the March 31st total of 1,030,000 shares. Based on an average daily volume of 169,000 shares, the short-interest ratio is […]
Marquette Asset Management LLC Has $105,000 Position in Nektar Therapeutics (NASDAQ:NKTR) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.